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A B S T R A C T
The synovial fluids of patients with osteoarthritis (OA) contain elevated levels of inflammatory cytokines, which
induce the expression of a disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) and of the
matrix metalloproteinase (MMP) in chondrocytes. Mechanical strain has varying effects on organisms depending
on the strength, cycle, and duration of the stressor; however, it is unclear under inflammatory stimulation how
mechanical strain act on. Here, we show that mechanical strain attenuates inflammatory cytokine-induced ex-
pression of matrix-degrading enzymes. Cyclic tensile strain (CTS), as a mechanical stressor, attenuated inter-
leukin (IL)-1β and tumor necrosis factor (TNF)-α-induced mRNA expression of ADAMTS4, ADAMTS9, and MMP-
13 in normal chondrocytes (NHAC-kn) and in a chondrocytic cell line (OUMS-27). This effect was abolished by
treating cells with mechano-gated channel inhibitors, such as gadolinium, transient receptor potential (TRP)
family inhibitor, ruthenium red, and with pharmacological and small interfering RNA-mediated TRPV1 in-
hibition. Furthermore, nuclear factor κB (NF-κB) translocation from the cytoplasm to the nucleus resulting from
cytokine stimulation was also abolished by CTS. These findings suggest that mechanosensors such as the TRPV
protein are potential therapeutic targets in treating OA.
1. Introduction
Osteoarthritis (OA) is the most common chronic disorder affecting
the joints and constitutes a major burden on public health. It is believed
that the articular cartilage—which consists of chondrocytes and extra-
cellular matrix (ECM) molecules including aggrecan, collagen, and
hyaluronan (HA) [1,2]—in patients with OA is destroyed by the aber-
rant up-regulation of matrix-degrading proteinases; however, it has
been demonstrated that the synovial fluid contains elevated levels of
inflammatory cytokines [3] that induce expression and activity of
matrix metalloproteinase (MMP), a disintegrin and metalloproteinase
with thrombospondin motifs (ADAMTS) [4–7]. ADAMTS4, ADAMTS5,
and ADAMTS9 cleave aggrecan, which holds water via its charged
chondroitin sulfate and keratan sulfate chains; thereby conferring
physical strength and stress resistance to cartilage [8]. In cartilage af-
fected by OA, aggrecan and collagen are degraded [5]. We recently
reported that inflammatory cytokines induce the expression of
ADAMTS9 to a greater extent than that of ADAMTS4 and of ADAMTS5
in chondrocytes [6], suggesting that ADAMTS9 plays an important role
in developing OA. We also found that HA treatment decreased
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ADAMTS9 levels in human and rat chondrocytes, it protected articular
cartilage in a rat model with OA by down-regulating aggrecanase [6].
Mechanical strain can induce the expression of ECM proteins in-
cluding collagen and aggrecan; however, excessive amounts of me-
chanical stress can actually stimulate proteases in chondrocytes instead
[9–11]. Various molecules, including integrins, function as sensors that
transduce mechanical stress [12]. Integrins are transmembrane glyco-
proteins composed of α and β subunits, each with an extracellular do-
main that directly binds ECM proteins such as collagen, fibronectin, and
vitronectin [13], as well as with a cytoplasmic domain that interacts
with the cytoskeleton via focal adhesion molecules. Transient receptor
potential (TRP) channels were first identified in Drosophila as six-
transmembrane proteins that function in phototransduction [14]. The
TRP family is subdivided into seven subfamilies: TRPC, TRPV, TRPM,
TRPP, TRPML, TRPA, and TRPN; these channels are expressed in a
variety of tissues and cell types and are mostly permeable to calcium,
some also presumably to act as mechanosensors [15,16].
Currently, it is unknown whether mechanical strain can suppress or
attenuate inflammatory cytokine-induced cellular responses. To address
these questions, the present study investigated changes in gene ex-
pression in chondrocytes subjected to uniaxial cyclic stretching. Our
results show that mechanical strain attenuates inflammatory cytokine-
induced expression of matrix-degrading enzymes. Moreover, we de-
termined that calcium channels function as mechanosensors and that
mechanical strain inhibits the release of cytokine-induced calcium in
chondrocytes; furthermore, it also blocks translocation of nuclear NF-κB
from the cytoplasm to the nucleus induced by cytokine stimulation.
These findings can provide a molecular basis for developing novel
strategies for regenerating cartilage and treating OA.
2. Methods
2.1. Reagents
Recombinant human interleukin (IL)-1β and tumor necrosis factor
(TNF)-α, purchased from R&D Systems (Minneapolis, MN, USA), was
stored at −80 °C and diluted in culture medium immediately before
use. Mechanosensor inhibitors (gadolinium, ruthenium red, capsaze-
pine, tranilast, and HC067047) and the NF-κB inhibitor (1,2-bis(2-
aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid tetrakis (acetox-
ymethyl ester) [BAPTA-AM]) were purchased from Sigma-Aldrich (St.
Louis, MO, USA).
2.2. Cells and cell culture
Normal human articular chondrocytes from knee cells (NHAC-kn)
were purchased from Lonza (Walkersville, MD, USA) and cultured at
37 °C in chondrocyte basal medium (Lonza) containing chondrocyte
growth medium, fetal bovine serum (FBS), transforming growth factor
β, R3 insulin-like growth factor, transferrin, insulin, gentamicin, and
amphotericin-B (CDM Bullet Kit; Lonza) as previously described [6].
The medium was changed every 3 days, only cells at passages 3–6 were
used for all experiments.
OUMS-27 chondrosarcoma cells were prepared as previously de-
scribed [6,17,18]. The cells were cultured in Dulbecco's modified Ea-
gle's medium (DMEM) containing 10% FBS and penicillin/streptomycin
at 37 °C in a humidified atmosphere with 5% CO2. Cells were passaged
to cell ratio of 1:2 or 1:4 using trypsin with ethylenediaminetetraacetic
acid every 7–10 days, with medium replacement every 3 days. Only
cells at passages 7–12 were used for experiments; 2.5× 105 cells were
seeded in 6-well plates for 2 days, and the medium was replaced with
serum-free medium for 24 h before cytokine stimulation, after which
the cells were cultured in the presence of IL-1β and TNF-α (both at
10 ng/mL).
2.3. Mechanical stimulation
Cells (1.5× 105) were seeded in a stretch chamber coated with
0.1 mg/mL collagen and cultured for 2 days, then transferred to serum-
free DMEM for 24 h. Cells were exposed to cycles of uniaxial stretching
in the presence of IL-1β and TNF-α (both at 10 ng/mL) using a ShellPa
mechanical stretch system (Menicon Life Science, Aichi, Japan) (n=6
each), which allowed for uniform stretching of the entire silicone
membrane.
2.4. Real-time quantitative reverse transcription PCR (qRT)-PCR
Following cytokine stimulation, cells were washed twice with
phosphate-buffered saline (PBS) and total RNA was extracted using
TRIzol reagent (Invitrogen, Carlsbad, CA, USA), according to the
manufacturer's instructions, and reverse transcribed into cDNA as pre-
viously described [19–21]. Briefly, genomic DNA was removed by
treatment with 5 U DNase I (Roche Diagnostics, Lewes, UK) at 37 °C for
15min, followed by enzyme inactivation at 65 °C for 10min; 2 μg total
RNA were reverse transcribed with random primers (Toyobo, Osaka,
Japan). qRT-PCR was carried out on a StepOnePlus system (Applied
Biosystems, Foster City, CA, USA) as previously reported [22–24], with
slight modifications. Briefly, each reaction mixture contained 5 μl
TaqMan Fast Advanced Master mix, 0.5 μl TaqMan Gene Expression
assay for the target genes (ADAMTS4, ADAMTS9, MMP-13, TRPV1,
TRPV2, and TRPV4) and the endogenous control (glyceraldehyde 3-
phosphate dehydrogenase; GAPDH), and 4 μl cDNA. Cycling conditions
were as follows: 95 °C for 20 s; and 40 cycles at 95 °C for 1 s and 60 °C
for 20 s. All samples were analyzed in triplicate. TaqMan primers and
probes (human ADAMTS4: assay ID Hs00192708_m1 based on RefSeq
NM_005099.4; human ADAMTS9: assay ID Hs00172025_m1 based on
Ref Seq NM_182,920.1; human MMP-13: assay ID Hs00233992_m1
based on RefSeq NM_002427.3; human TRPV1: assay ID Hs0021912_m1
based on Ref seq NM_018,727.5; human TRPV2: assay ID
Hs00901648_m1 based on Ref seq NM_016,113.4; human TRPV4: assay
ID Hs01099348_m1 based on Ref seq NM_001177428.1; human
GAPDH: assay ID Hs02758991_g1 based on Ref Seq NM_001256799.1)
as well as the TaqMan Fast Advanced Master Mix were purchased from
Applied Biosystems. GAPDH was used to normalize the levels of target
RNAs with the comparative Ct (ΔΔCT) method as previously described
[25–27]. Values obtained from the untreated cells served as the control.
2.5. Treatment with mechanosensor inhibitors
Cells (1.5× 105) were seeded in a stretch chamber coated with
0.1 mg/mL collagen and cultured for 2 days, then transferred to serum-
free DMEM for 24 h. Cells were pretreated with the following me-
chanosensor inhibitors for 1 h: the integrin-binding motif peptide
GRGDS (50 μg/mL; Sigma-Aldrich) and its analog GRADSP (50 μg/mL;
Calbiochem, Nottingham, UK), gadolinium (10 μM), ruthenium red
(10 μM), capsazepine (10 μM), tranilast (50 μM), and HC-067047
(5 μM). The cells were then subjected to cycles of uniaxial stretching
(5%, 0.5 Hz) in the presence of IL-1β and TNF-α (both at 10 ng/mL)
using the ShellPa mechanical stretch system.
2.6. RNA interference
To silence TRPV1, TRPV2, and TRPV4, we used predesigned small
interfering siRNAs (Silencer Select Pre-designed siRNAs; Ambion,
Foster City, CA, USA) as previously described [28]. OUMS-27 cells were
seeded at 1.5× 105 cells/well in a collagen-coated stretch chamber and
transfected with human TRPV1-1 (assay ID, s14819 based on RefSeq
NM_018,727.5), human TRPV1-2 (assay ID, s14817 based on RefSeq
NM_018,727.5), human TRPV2-1 (assay ID, s28081 based on RefSeq
NM_016,113.4), human TRPV2-2 (assay ID, s28082 based on RefSeq
NM_016,113.4), human TRPV2-3 (assay ID, s28083 based on RefSeq
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NM_016,113.4), human TRPV4-1 (assay ID, s531655 based on RefSeq
NM_001177428.1), human TRPV4-2 (assay ID, s531654 based on Re-
fSeq NM_001177428.1), and human TRPV4-3 (assay ID, s531656 based
on RefSeq NM_001177428.1) at a final concentration of 10 nM with
Lipofectamine RNAiMAX transfection reagent, (Thermo Fisher Scien-
tific, Waltham, MA, USA) according to the manufacturer's protocol.
Silencer Select Negative Control No. 1 siRNA (4390843) was used as
negative control. Cells were subsequently incubated 24 h before being
exposed to CTS stimulation in the presence of IL-1β and TNF-α (both at
10 ng/mL) using the ShellPa mechanical stretch system before they
were collected for analysis. Target gene knockdown efficiency was
confirmed by qRT-PCR.
2.7. Visualization of intracellular calcium
OUMS-27 cells (1.5× 105) were seeded in collagen-coated glass-
bottomed plates and cultured for 2 days, then washed twice with PBS
and treated with 5 μM Fluo-4 AM in DMEM for 1 h. After washing the
cells in PBS, the nuclei were stained with Hoechst 33258 (Sigma-
Aldrich; 1:5000). The samples were mounted with coverslips and stored
at 4 °C in the dark. Images were obtained with a microscope (BZ-X700;
KEYENCE, Oosaka, Japan) [29–31].
2.8. Evaluation of NF-κB translocation
Cells (1.5× 105) were seeded in a stretch chamber coated with
0.1 mg/mL collagen and cultured for 2 days before being transferred to
serum-free DMEM for 24 h. After treatment with IL-1β and TNF-α (both
at 10 ng/mL), with or without 0.5-Hz cycles of uniaxial stretching
(n=6 each), the cells were treated with cold methanol for 30min,
followed by cold acetone treatment for 10min for fixation with per-
meabilization. After washing the cells in PBS, samples were blocked
with 3% bovine serum albumin/PBS for 2 h, washed in PBS, and in-
cubated overnight at 4 °C with anti–NF–κB p65 antibody (Santa Cruz
Biotechnology, Dallas, TX, USA; 1:500, sc-372). After PBS washes, cells
were incubated for 1 h at 20 °C with Alexa 488-conjugated anti-rabbit
secondary antibody (Invitrogen), then washed in PBS. The nuclei were
stained with Hoechst 33,258 (1:5000) and the samples were mounted
with coverslips and stored in the dark at 4 °C. Images were obtained
with a microscope (BZ-X700; KEYENCE).
2.9. BAPTA-AM treatment
Cells (2.5× 105) were seeded in a 6-well plate and cultured for 2
days, then transferred to serum-free DMEM for 24 h. The cells were
treated IL-1β and TNF-α (both at 10 ng/mL) for 6 h with or without a
1 h pretreatment with 30 μM BAPTA-AM. ADAMTS9 transcript levels
were evaluated relative to levels in unstimulated cells by qRT-PCR.
2.10. Statistical analysis
Data are expressed as the mean ± SD. Differences among groups
were evaluated by analysis of variance followed by Bonferroni's test. P
values < 0.05 were considered statistically significant.
3. Results
3.1. Mechanical strain attenuates inflammatory cytokine-induced
expression of ADAMTS and MMP in OUMS-27 cells
First, we examined whether mechanical strain attenuates expression
of ADAMTS4, ADAMTS9, and MMP13 induced by IL-1β and TNF-α in
OUMS-27 cells. Application of 5% CTS at a frequency of 0.5 Hz resulted
in the downregulation of ADAMTS4, ADAMTS9, and MMP13 transcript
levels in OUMS-27 cells stimulated with cytokines (Fig. 1).
3.2. Mechanical strain attenuates inflammatory cytokine-induced
expression of ADAMTS9 in human chondrocytes
We examined whether mechanical strain attenuates expression of
ADAMTS9 mRNA induced by IL-1β and TNF-α in chondrocytes from
non-OA patients. As expected, treatment of NHAC-kn cells with 5%
tensile strain at 0.5-Hz frequency reduced cytokine-induced expression
ADAMTS9 mRNA in these cells (Fig. 2).
3.3. Mechanical strain conditions
We examined the effects of different mechanical strain conditions
on expression ADAMTS9mRNA induced by cytokines in OUMS-27 cells.
The levels of ADAMTS9 mRNA in cells treated with IL-1β and TNF-α
decreased as the frequency increased (0.16, 0.33, and 0.5 Hz at 5%
tensile strain; Fig. 3A) and tensile strain (2.0%, 3.0%, and 5.0% at 0.5-
Hz frequency; Fig. 3B).
3.4. Pretreatment with integrin binding motif peptide does not influence
response to mechanical strain
Previous studies have shown that integrin functions as a mechan-
osensor [10]. Integrin binds to the ECM and associates with cytoskeletal
actin filaments via linker proteins to physically connect intra- and ex-
tracellular structures. We found here that pretreatment with the in-
tegrin binding motif sequence GRGDS and its analog GRDSP did not
alter expression of ADAMTS9 mRNA in OUMS-27 cells (Fig. 4), in-
dicating that integrin binding is unlikely involved in the cellular re-
sponse to mechanical strain.
3.5. Mechanosensor inhibitors abrogate the impact of mechanical strain
Pretreatment with gadolinium (a broad-spectrum mechanosensor
inhibitor) reversed the negative effects of mechanical strain on cyto-
kine-induced ADAMTS9 upregulation (Fig. 5A), whereas gadolinium on
its own had no effect on the expression of ADAMTS9 mRNA. Similar
Fig. 1. Cytokine-induced expression of ADAMTS4, ADAMTS9, and MMP-
13mRNA in OUMS-27 cells is attenuated by CTS. Cells were subjected to 5%
tensile strain at a frequency of 0.5 Hz and treated with 10 ng/mL IL-1β and
TNF-α for 6 h. Levels of ADAMTS4, ADAMTS9, and MMP-13mRNA were
measured relative to the levels of mRNA found in the unstimulated control cells
by qRT-PCR. Open bars; ADAMTS4, closed bars; ADAMTS9, hatched bars;
MMP-13. Values represent mean ± SD (n= 6 per group). ##P < 0.01 vs.
control; **P < 0.01 vs. cytokine-treated group.
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effects were observed with ruthenium red (TRPV family inhibitor)
(Fig. 5B) and capsazepine (TRPV1 inhibitor) pretreatment. On the other
hand, tranilast (TRPV2 inhibitor) and HC-067047 (TRPV4 inhibitor)
pretreatment did not downregulate strain-induced expression of
ADAMTS9 mRNA in cytokine-treated cells (Fig. 5B).
3.6. TRPV silencing abolishes the effects of mechanical strain
To identify which TRPV family molecules mediate the effects of
mechanical strain, we knocked down the expression of TRPV1, TRPV2,
and TRPV4. Each of the siRNAs—but the not the scrambled control
siRNAs—reduced the level of its target mRNA (Fig. 6B). Pretreatment
with siRNAs (V1-1 and V1-2) against TRPV1 abolished the impact of
mechanical strain in OUMS-27 cells (Fig. 6A); however, pretreatment
with siRNAs against TRPV2 (V2-1, V2-3, and V2-3) and TRPV4 (V4-1,
V4-2, and V4-3) did not alter the effects of mechanical strain (Fig. 6A).
None of the siRNAs or the scrambled control RNAs used in this ex-
periment affected cell viability or expression of ADAMTS9 mRNA (data
Fig. 2. CTS attenuates cytokine-induced expression of ADAMTS9 mRNA in
NHAC-kn cells. NHAC-kn cells were subjected to 5% tensile strain at a fre-
quency of 0.5 Hz and treated with 10 ng/mL IL-1β and TNF-α for 6 h. The
number ADAMTS9 transcripts was measured relative to the levels of mRNA
found in unstimulated the control cells by qRT-PCR. Values represent
mean ± SD (n= 6 per group). ##P < 0.01 vs. control; **P < 0.01 vs. cy-
tokine-treated group.
Fig. 3. CTS attenuates cytokine-induced expression of ADAMTS9 mRNA in OUMS-27 cells. (A) Effect of frequency. Cells were subjected to 5% tensile strain at a
frequency of 0, 0.16, 0.33, and 0.5 Hz and treated with 10 ng/mL IL-1β and TNF-α for 6 h. (B) Effect of tensile strain. Cells were treated 0.5 Hz of frequency with 0,
3.0 and 5.0 tensile strain along with 10 ng/mL IL-1β and TNF-α for 6 h. The number of ADAMTS9 transcripts was measured relative to levels of mRNA number in the
unstimulated cells by qRT-PCR. Values represent mean ± SD (n=6 per group). ##P < 0.01 vs. control; **P < 0.01 vs. cytokine-treated group.
Fig. 4. Integrin binding motif peptide does not inhibit the effects of mechanical
strain. Cells were pretreated with the integrin-binding peptide GRGDS (5 μg/
mL) or its analog GRADSP (5 μg/mL) for 1 h and then cultured in the presence
of IL-1β and TNF-α (both at 10 ng/mL) with cyclic tensile strain (5%, 0.5 Hz)
for 6 h. The number of ADAMTS9 transcripts was measured relative to the levels
of mRNA found in unstimulated the control cells by qRT-PCR. Values represent
mean ± SD (n=6 per group). ##P < 0.01 vs. control; **P < 0.01 vs. cy-
tokine-treated group.
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not shown).
3.7. Effects of inflammatory cytokines on intracellular calcium
concentration in OUMS-27 cells
We examined whether inflammatory cytokines can influence in-
tracellular calcium concentrations in OUMS-27 cells using Fluo-4 AM
(Fig. 7). Treatment with IL-1β and TNF-α (both at 10 ng/mL) increased
intracellular calcium content after 10 and 30min of cytokine stimula-
tion; however, after 60min, the concentration declined.
3.8. BAPTA-AM suppresses expression of ADAMTS9 in OUMS-27 cells
We examined whether NF-κB inhibition by BAPTA-AM alters the
expression of ADAMTS9 mRNA and found that BAPTA-AM pretreat-
ment decreased cytokine-induced expression of ADAMTS9 after 6 h
(Fig. 8).
3.9. Mechanical strain blocks cytokine-induced NF-κB nuclear translocation
in OUMS-27 cells
We explored the intracellular mechanisms of mechanical strain by
analyzing nuclear translocation of NF-κB—a key transcription factor
involved in signal transduction of inflammatory cytokines—by im-
munofluorescence analysis. Rapid nuclear translocation of NF-κB was
observed within 10min of IL-1β and TNF-α treatment (Fig. 9); on the
other hand, NF-κB was retained in the cytoplasm under mechanical
strain for 6 h with IL-1β and TNF-α treatment (data not shown). In
contrast, cells treated simultaneously with mechanical strain and cy-
tokines exhibited strong suppression of IL-1β- and TNF-α-induced NF-
κB nuclear translocation (Fig. 9).
3.10. Mechanical strain inhibits the cytokine-induced calcium increase in
OUMS-27 cells
We investigated intracellular calcium kinetics by immuno-
fluorescence analysis. Rapid calcium upregulation was observed within
10min of adding IL-1β and TNF-α (Fig. 10). In contrast, cells subjected
to CTS with simultaneous cytokine treatment showed strong suppres-
sion of the IL-1β- and TNF-α-induced increase in calcium content
(Fig. 10). CST alone caused a slight elevation in intracellular calcium.
4. Discussion
In this study, we examined the effects of mechanical strain on in-
flammatory cytokine-induced expression of ADAMTS9 mRNA and the
underlying mechanisms in chondrocytes. We found that intracellular
calcium and translocation of the NF-κB nuclear factor increased in the
presence of cytokines, whereas mechanical strain reversed this effect
via TRPV1, resulting in downregulation of ADAMTS9.
Cultured chondrocytes have been exposed to CTS stimulation at a
wide range of strain magnitudes and durations with various systems
[32–34]. Xu et al. (2000) reported that CTS acts as an antagonist of IL-
1β actions in chondrocytes [32]. Although the mechanism has not yet
been elucidated, they reported that CTS attenuates the induction of IL-
1β-induced inflammatory responses. Interestingly, CTS had lower effect
on inflammatory signals when inflammatory cytokines were not asso-
ciated with it. Hayashi et al. (2015) reported that p21 plays a role in the
expression of MMP13 mRNA in response to CTS [10]. CTS increased
p21 expression and this effect was mediated by signal transducer and
activator of transcription 3 (STAT3). Recently, Lohberger et al. (2019)
reported that moderate tensile strain most effectively reduces
ADAMTS5 and MMP13 expression levels in chondrocytes compared to
strong tensile strain [33]. They also demonstrated that moderated
tensile strain significantly decreases the expression of IL-6, a notable
inflammatory marker. Their results suggested that different loading
conditions cause different effects on the expression of inflammatory
markers and MMPs/ADAMTSs in chondrocytes. Recently, Papado-
poulou et al. (2019) reported that CTS immediately activates extra-
cellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase
(JNK) in human periodontal ligament fibroblasts [34]. They also de-
monstrated that CTS induces c-fos activation. These accumulating evi-
dences led to the hypothesis that CTS attenuates IL-1β-induced
ADAMTS9 expression. Notably, the effect of CTS is altered depending
on its conditions such as magnitudes, durations, and frequency. Our
data suggests that CTS (0.16–0.50 Hz with 5% elongation or 0.5 Hz with
2.0%–5.0% elongation) reduces levels of ADAMTS9 mRNA in cytokine-
stimulated chondrocytes (Fig. 3B). The duration of cytokine exposure
and mechanical strain treatment was an important factor; the degree of
attenuation was reduced by a shorter duration of mechanical strain
(data not shown). Based on these data, we considered that the CTS
condition used in the present study demonstrated the antagonistic ef-
fects in IL-1β stimulated chondrocytes via TRPV.
Previous in vitro and in vivo studies revealed that there is a stronger
Fig. 5. Mechano-gated channel inhibition abrogates CTS attenuation. (A) Cells
were pretreated with gadolinium (10 μM) for 1 h and then cultured in the
presence of IL-1β and TNF-α (both at 10 ng/mL) with cyclic tensile strain (5%,
0.5 Hz) for 6 h. (B) Cells were pretreated with ruthenium red (10 μM), capsa-
zepine (10 μM), tranilast (50 μM), or HC-067047 (5 μ M) for 1 h and then cul-
tured in the presence of IL-1β and TNF-α (both at 10 ng/mL) with cyclic tensile
strain (5%, 0.5 Hz) for 6 h. The number of ADAMTS9 transcripts was measured
relative to the levels of mRNA found in the unstimulated control cells by qRT-
PCR. Values represent mean ± SD (n= 6 per group). ##P < 0.01 vs. control;
**P < 0.01 vs. cytokine-treated group.
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Fig. 6. TRPV knockdown abrogates CTS attenuation. Cells were transfected with siRNAs against TRPV1 (V1-1 and V1-2), V2 (V2-1, V2-2, and V2-3), and V4 (V4-1,
V4-2 and V4-3) for 24 h and then cultured in the presence of IL-1β and TNF-α (both at 10 ng/mL) with cyclic tensile strain (5%, 0.5 Hz) for 6 h. The number of
ADAMTS9 transcripts was measured relative to the levels of mRNA number found in the unstimulated control cells by qRT-PCR. Values represent mean ± SD (n=6
per group). ##P < 0.01 vs. control; **P < 0.01 vs. cytokine-treated group.
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expression of ADAMTS9 in chondrocytes than ADAMTS4 and
ADAMTS5, indicating that it is more likely involved in articular carti-
lage degradation in OA. We have previously reported that nuclear
factor of activated T cells, cytoplasmic, calcineurin-dependent 1
(NFATc1) regulates expression of ADAMTS9 in chondrocytes via IL-1β,
and that a treatment with the NFATc1-specific inhibitor reduces levels
of ADAMTS9 [35], implying that expression of ADAMTS9 is regulated
by different mechanisms. It is well known that NF-κB is widely used as
transcription factor for matrix degradative molecules (ADAMTS4, 5, 9,
18, MMP-1, 2, 3, 8, 9, 13) under inflammatory stimulation [36]. It
appears that NF-κB regulation is important for OA therapy. Yang et al.
(2019) reported that CTS alleviates the chondrocyte damage induced by
IL-1β by activating AMP-activated protein kinase (AMPK) phosphor-
ylation and suppressing nuclear translocation of NF-κB [37]. They
proposed that moderate AMPK, activated by moderated CTS, reduces
intracellular ROS production, which inhibits nuclear translocation of
NF-κB. Their data were consistent with our results; therefore, a similar
underlying mechanism is suggested.
In order to analyze the molecular mechanism of OA, we measured
the effects of mechanical strain on expression of ADAMTS9 using
NHAC-kn and OUMS-27 cell lines, which exhibit particular chondrocyte
properties such as expression of the chondrocyte-specific ECM genes
type II, IX, and XI collagen and aggrecan; moreover, treatment with IL-
1β and TNF-α induced expression of ADAMTS4 and ADAMTS9 after 6 h
in both cell lines, and with similar kinetics [6,17]. Aggrecan cleavage
by ADAMTS was also observed in OUMS-27 cells (data not shown),
suggesting that these cells can serve as a model for investigating the
effects of cytokines on expression of ADAMTS.
Chondrocytes are surrounded by ECM. Integrins are transmembrane
receptors that facilitate cell–ECM adhesion by binding specific integrin
subtypes to activate signal transduction [11]. There is evidence that
integrins function as mechanosensors [38]. CTS increased expression of
collagen (COL1A1 and COL3A1) via integrin αVβ3, which binds to the
Arg-Gly-Asp (RGD) motif [11]. Integrins transduce mechanical signals
in annulus fibrosus cells, whereas the RGD peptide suppresses phos-
phorylation of focal adhesion kinase induced by severe CTS (10%,
Fig. 7. Cytokine treatment increases intracellular calcium levels. OUMS-27 cells were seeded in glass-bottomed dishes for 48 h. After culturing cells overnight serum
starvation, the cells were treated for 1 h with 5 μM Fluo-4 AM to visualize intracellular Calcium (green), followed by IL-1β and TNF-α (both at 10 ng/mL) for 10, 30,
and 60min. Cells were fixed by placing them in cold methanol for 30min and in cold acetone for 10min. After washing, the nuclei were stained with Hoechst 33258
(blue).
Fig. 8. BAPTA-AM attenuates cytokine-induced ADAMTS9 expression in
chondrocytes. OUMS-27 cells were treated with IL-1β and TNF-α (both at
10 ng/mL) for 6 h with or without 30 μM BAPTA-AM. The number of ADAMTS9
transcripts was measured relative to the levels of mRNA found in the un-
stimulated control cells by qRT-PCR. Values represent mean ± SD (n= 6 per
group). ##P < 0.01 vs. control; **P < 0.01 vs. cytokine-treated group.
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1.0 Hz) [39]. Mechanical strain also induced hyperpolarization of the
membrane in primary chondrocytes via α5β1 integrin, but could be
reversed by RGD peptide [40]. On the other hand, we found that the
RGD peptide did not attenuate cytokine-induced expression of
ADAMTS9 in OUMS-27 cells, implying that this integrin does not par-
ticipate in this mechanism. On the other hand, pretreatment with ga-
dolinium, which inhibits several types of Ca+ channels [41], abrogated
the impact of mechanical strain on expression of ADAMTS9 mRNA,
implying that calcium signaling is involved. We, therefore, focused on
the function of calcium channels as possible mechanosensors using a
variety of TRPV-specific inhibitors [42–46], and demonstrated that
pretreatment with ruthenium red, a well-known TRPV family inhibitor
[47], as well as capsazepine, a TRPV1 inhibitor, abolished the effects of
mechanical stress. However, tranilast and HC-067047 (inhibitors of
TRPV2 and TRPV4, respectively) did not have this effect. TRPV4 is
highly expressed in both bone and cartilage [48,49]. Similarly,
knocking down TRPV1 abrogated the effect of mechanical strain,
whereas silencing other TRPV types (TRPV2 and TRPV4), on the other
hand, did not. Based on these results, we conclude that TRPV1 mediates
the effects of mechanical strain on expression of ADAMTS9.
Intracellular calcium levels are tightly controlled in cells. In their
resting state, cells maintain a 20,000-fold gradient of calcium con-
centration between the cytosol (100 nM) and the extracellular space
(mM) [50]. The rapid increase in calcium in the cytoplasm is achieved
through a calcium influx from the extracellular environment or through
its release from intracellular calcium stores such as the endoplasmic
reticulum (ER). The ER is also a major intracellular calcium reservoir
[51]. In chondrocytes, both mechanisms are critical for regulating
physical stimulus-induced responses [52]. Even a single cycle of me-
chanical stress was found to instantly increase cytoplasmic calcium
concentrations in OUMS-27 cells (data not shown). Our results clearly
demonstrated that CTS decreased intracellular levels of cytokine-in-
duced calcium and blocked cytokine-induced translocation of NF-κB
from the cytoplasm to the nucleus in OUMS-27 cells. NF-κB transloca-
tion needs several steps; intracellular calcium up-regulation, Calcium/
calmodulin-dependent protein kinase II (CaMKII) activation, IκB
Fig. 9. Mechanical strain inhibits translocation of cytokine-induced NF-κB (p65) from cytoplasm to nucleus. OUMS-27 cells were seeded on a collagen-coated stretch
chamber. After an overnight serum starvation, the cells were treated with IL-1β and TNF-α (both at 10 ng/mL) for 10min with or without uniaxial strain (0.5-Hz
cycles of stretch). Afterwards, the cells were fixed with cold methanol for 30min followed by cold acetone for 10min. After washing and blocking, NF-κB p65 (green)
was detected by immunocytochemistry and nuclei were stained with Hoechst 33258 (blue).
Fig. 10. Mechanical strain inhibits cytokine-induced calcium concentration in the cytoplasm. OUMS-27 cells were seeded on the collagen-coated stretch chamber.
After an overnight starvation treatment, cells were treated with 5 μM Fluo-4 AM for 1 h to visualize intracellular Calcium (green), followed by IL-1β and TNF-α (both
at 10 ng/mL) for 10min with or without uniaxial strain (0.5-Hz cycles of stretch). The cells were fixed with cold methanol for 30min, and cold acetone for 10min.
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phosphorylation and release from complex, NF-κB delivery to the nu-
clear membrane via molecular motor and few more steps [53]. There-
fore, we propose the following hypothetic model to explain our results:
translocation of NF-κB requires high concentrations of calcium for
CaMKII activation; cytokines stimulate the release of calcium from the
ER but mechanical strain activates TRPV1 in the plasma membrane,
resulting in the release of calcium into the culture medium, NF-κB in-
activation, attenuation of cytokine induced ADAMTS9 expression.
In conclusion, mechanical strain attenuates cytokine-induced ex-
pression of ADAMTS and MMP in chondrocytes; the calcium channel
and mechanosensor TRPV1 mediates the effect of mechanical strain on
the expression of matrix-degrading enzymes. Our findings provide in-
sight into the regulation of ADAMTS9 mRNA expression in chon-
drocytes and suggest that mechanosensors such as TRPV can serve as
therapeutic targets for treating OA.
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